BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11403151)

  • 1. Role of type 10 17beta-hydroxysteroid dehydrogenase in the pathogenesis of Alzheimer's disease.
    Yang SY; He XY
    Adv Exp Med Biol; 2001; 487():101-10. PubMed ID: 11403151
    [No Abstract]   [Full Text] [Related]  

  • 2. Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer's Disease.
    He XY; Isaacs C; Yang SY
    J Alzheimers Dis; 2018; 62(2):665-673. PubMed ID: 29480196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase.
    Yang SY; He XY; Schulz H
    Trends Endocrinol Metab; 2005; 16(4):167-75. PubMed ID: 15860413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deposition of Alzheimer's vascular amyloid-beta is associated with decreased expression of brain L-3-hydroxyacyl-coenzyme A dehydrogenase (ERAB).
    Frackowiak J; Mazur-Kolecka B; Kaczmarski W; Dickson D
    Brain Res; 2001 Jul; 907(1-2):44-53. PubMed ID: 11430884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and localization of human type10 17beta-hydroxysteroid dehydrogenase.
    He XY; Merz G; Yang YZ; Mehta P; Schulz H; Yang SY
    Eur J Biochem; 2001 Sep; 268(18):4899-907. PubMed ID: 11559359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique multifunctional HSD17B4 gene product: 17beta-hydroxysteroid dehydrogenase 4 and D-3-hydroxyacyl-coenzyme A dehydrogenase/hydratase involved in Zellweger syndrome.
    de Launoit Y; Adamski J
    J Mol Endocrinol; 1999 Jun; 22(3):227-40. PubMed ID: 10343282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of hydroxysteroid dehydrogenase type 10 in amyloid plaques (APs) of Hsiao's APP-Sw transgenic mouse brains, but absence in APs of Alzheimer's disease brains.
    Wen GY; Yang SY; Kaczmarski W; He XY; Pappas KS
    Brain Res; 2002 Nov; 954(1):115-22. PubMed ID: 12393239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abundant type 10 17 beta-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model.
    He XY; Wen GY; Merz G; Lin D; Yang YZ; Mehta P; Schulz H; Yang SY
    Brain Res Mol Brain Res; 2002 Feb; 99(1):46-53. PubMed ID: 11869808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD).
    Powell AJ; Read JA; Banfield MJ; Gunn-Moore F; Yan SD; Lustbader J; Stern AR; Stern DM; Brady RL
    J Mol Biol; 2000 Oct; 303(2):311-27. PubMed ID: 11023795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABAD: a potential therapeutic target for Abeta-induced mitochondrial dysfunction in Alzheimer's disease.
    Marques AT; Fernandes PA; Ramos MJ
    Mini Rev Med Chem; 2009 Jul; 9(8):1002-8. PubMed ID: 19601895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17β-Hydroxysteroid Dehydrogenase in Neurodegeneration Study.
    He XY; Dobkin C; Brown WT; Yang SY
    J Alzheimers Dis; 2022; 88(4):1487-1497. PubMed ID: 35786658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic alcohol dehydrogenase and hydroxysteroid dehydrogenase activities of human mitochondrial short-chain L-3-hydroxyacyl-CoA dehydrogenase.
    He XY; Yang YZ; Schulz H; Yang SY
    Biochem J; 2000 Jan; 345 Pt 1(Pt 1):139-43. PubMed ID: 10600649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mitochondrial enzyme ABAD and its role in the development and treatment of Alzheimer's disease].
    Benek O; Musílek K; Kuca K
    Ceska Slov Farm; 2012 Aug; 61(4):144-9. PubMed ID: 23251955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease.
    Yang SY; He XY; Schulz H
    FEBS J; 2005 Oct; 272(19):4874-83. PubMed ID: 16176262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxysteroid (17β) dehydrogenase X in human health and disease.
    Yang SY; He XY; Miller D
    Mol Cell Endocrinol; 2011 Aug; 343(1-2):1-6. PubMed ID: 21708223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative 3alpha-hydroxysteroid dehydrogenase activity of human type 10 17beta-hydroxysteroid dehydrogenase.
    He XY; Yang YZ; Peehl DM; Lauderdale A; Schulz H; Yang SY
    J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):191-8. PubMed ID: 14672739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human brain short chain L-3-hydroxyacyl coenzyme A dehydrogenase is a single-domain multifunctional enzyme. Characterization of a novel 17beta-hydroxysteroid dehydrogenase.
    He XY; Merz G; Mehta P; Schulz H; Yang SY
    J Biol Chem; 1999 May; 274(21):15014-9. PubMed ID: 10329704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning, modeling, and localization of rat type 10 17beta-hydroxysteroid dehydrogenase.
    He XY; Merz G; Chu CH; Lin D; Yang YZ; Mehta P; Schulz H; Yang SY
    Mol Cell Endocrinol; 2001 Jan; 171(1-2):89-98. PubMed ID: 11165016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphology-Specific Inhibition of β-Amyloid Aggregates by 17β-Hydroxysteroid Dehydrogenase Type 10.
    Aitken L; Quinn SD; Perez-Gonzalez C; Samuel ID; Penedo JC; Gunn-Moore FJ
    Chembiochem; 2016 Jun; 17(11):1029-37. PubMed ID: 26991863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human brain L-3-hydroxyacyl-coenzyme A dehydrogenase is identical to an amyloid beta-peptide-binding protein involved in Alzheimer's disease.
    He XY; Schulz H; Yang SY
    J Biol Chem; 1998 Apr; 273(17):10741-6. PubMed ID: 9553139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.